09/21/2026
This year's World Alzheimer's Awareness theme is, "The Earlier You Know, The More You Can Do: A Dementia Diagnosis Matters."
Plasma biomarkers are currently one of the earliest methods of detection of amyloid pathology, but as is common with recently approved test methodologies, there are a lot of questions surrounding how to interpret the tests, which patients should be tested, and when. To answer some of these questions, Medavera brought together three experts in a free CME/CE program for physicians, nurses, and laboratory professionals to provide education on the use of plasma biomarkers for Alzheimer's disease in neurology and primary care.
https://zurl.co/4AX7T
This program was planned and developed by Medavera and supported by Fujirebio.